Cannabix TechnologiesFRA:8CT +7.14%32 Median PS Value is €0.00 as of Jul. 08, 2026. GuruFocus rates FRA:8CT with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 336 Medical Devices & Instruments companies, Cannabix Technologies ranks worse than 297618.75% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Cannabix Technologies's Median PS Value or its related term are showing as below:
FRA:8CT's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.725 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Cannabix Technologies (FRA:8CT) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Cannabix Technologies's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.36
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabix Technologies Median PS Value Related Terms
Cannabix Technologies Median PS Value Historical Data
* Premium members only.
The historical data trend for Cannabix Technologies's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:8CT vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, Cannabix Technologies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabix Technologies Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Cannabix Technologies's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
Cannabix Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabix Technologies (FRA:8CT) has a Median PS Value of €0.00 as of Jul. 08, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Cannabix Technologies and its competitors. According to the industry distribution chart, Cannabix Technologies ranks #999999 out of 336 companies in the Medical Devices & Instruments industry.
Is Cannabix Technologies' Median PS Value too high?
Cannabix Technologies' current Median PS Value is €0.00. Based on the distribution chart, Cannabix Technologies ranks #999999 out of 336 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cannabix Technologies has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cannabix Technologies ranks #999999 out of 336 companies for Median PS Value. This places Cannabix Technologies in the lower half of its industry. The industry median Median PS Value is 0.73. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.73, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Cannabix Technologies and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabix Technologies's current Median PS Value is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (FRA:8CT) has a current Median PS Value of €0.00. The current Median PS Value is €0.00. Cannabix Technologies' overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Cannabix Technologies (FRA:8CT), the current Median PS Value is €0.00 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
32GF Score
Get the complete analysis for FRA:8CT
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8CT has been successfully added to your 
